NCT/Study#
N/A /
VENETOCLAX-AML
Effect of Adding Venetoclax to Intensive Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia
DISEASE GROUP:
Leukemia
current phase:
N/A
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
